Our data also showed that both the Glial fibrillary acidic protein (GFAP) and ionized calcium-binding adaptor molecule 1 (Iba-1) markers in the neuronal tissue homogenate were significantly increased in AD, and the treatment with NMP prominently reduced the expression of these markers. Here, AIF1 is linked to Alzheimer disease.